The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of the blockbuster breast cancer drug trastuzumab (Herceptin). Coincidentally, Lisa Coussens, PhD, MD (hc), FAACR, FAIO, who closed out her term as AACR President during the meeting, played a significant role in the story of trastuzumab. In … Continue reading 25 Years of Trastuzumab: A Legacy of Innovation